Pulse Explorar nav.journalClub Debates Tendências Pesquisadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Início Explorar nav.journalClub Tendências

⌘+K

Research Paper | Synapse

October 16, 2024Open Access

Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial

KMKeith W. MuirUniversity of Glasgow GFGary A. FordVascular Medicine IFIan FordUniversité Claude Bernard Lyon 1

Key Points

Key points are not available for this paper at this time.

Abstract

The Stroke Association and British Heart Foundation.

Perguntar à IA

Like

Bookmark

Share

View Full Paper

Perguntar à IA

Like

Bookmark

Share

View Full Paper

Cite This Study

Muir et al. (Wed,) studied this question.

synapsesocial.com/papers/69d709da65989f52c9ab32c9 https://doi.org/https://doi.org/10.1016/s1474-4422(24)00377-6

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial2022 · 463 citations
2Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke2023 · 64 citations
3European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke2023 · 213 citations
4Coagulation and Fibrinolytic Activity of Tenecteplase and Alteplase in Acute Ischemic Stroke2015 · 73 citations
5Improving the Reliability of Stroke Disability Grading in Clinical Trials and Clinical Practice2010 · 244 citations